United Nations. Population and Vitals Statistics Report. 2015.
IDF. IDF Diabetes Atlas, 7th edn. Brussels: International Diabetes Federation, 2015.
WHO. Global Status Report on Non-communicable Diseases 2010. Geneva: World Health Organization, 2011.
WHO. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization, 2008.
Gurdasani D, et al.
The African Genome Variation Project shapes medical genetics in Africa. Nature
2014; 517: 327–332.
Ferlay J, et al.
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer
2010; 127: 2893–2917.
Yusuf S, et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet
2004; 364: 937–952.
Murphy GA, et al.
Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study. International Journal of Epidemiology
2013; 42: 1740–1753.
BeLue R, et al.
An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and Health
2009; 5: 10.
Riha J, et al.
Urbanicity and lifestyle risk factors for cardiometabolic diseases in rural Uganda: a cross-sectional study. PLoS Medicine
2014; 11: e1001683.
Assah FK, et al.
Urbanization, physical activity, and metabolic health in sub-Saharan Africa. Diabetes Care
2011; 34: 491–496.
Sobngwi E, et al.
Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. International Journal of Epidemiology
2004; 33: 769–776.
Hawkes C. Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases. Globalization and Health
2006; 2: 4.
Kavishe B, et al.
High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Medicine
2015; 13: 126.
Ng M, et al.
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet
2014; 384: 766–781.
Torloni MR, et al.
Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obesity Reviews
2009; 10: 194–203.
Yu CK, Teoh TG, Robinson S. Obesity in pregnancy. British Journal of Obstetrics and Gynaecology
2006; 113: 1117–1125.
Yogev Y, Visser GHA. Obesity, gestational diabetes and pregnancy outcome. Seminars in Fetal and Neonatal Medicine
2009; 14: 77–84.
Wendland EM, et al.
Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth
2012; 12: 23.
Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic Medicine
2004; 21: 103–113.
Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care
2002; 25: 1862–1868.
Kaul P, et al.
Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: a population-level analysis. Diabetic Medicine
2014; 32: 164–173.
Boney CM, et al.
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics
2005; 115: e290–e296.
Uauy R, Kain J, Corvalan C. How can the Developmental Origins of Health and Disease (DOHaD) hypothesis contribute to improving health in developing countries?
American Journal of Clinical Nutrition
2011; 94(6 Suppl.): 1759s–1764s.
Barker DJ. Fetal origins of coronary heart disease. BMJ (Clinical research ed)
1995; 311: 171–174.
Barker DJ, et al.
Fetal nutrition and cardiovascular disease in adult life. Lancet
1993; 341: 938–941.
Gluckman PD, Hanson MA, Beedle AS. Non-genomic transgenerational inheritance of disease risk. BioEssays
2007; 29: 145–154.
Barker DJ. The origins of the developmental origins theory. Journal of Internal Medicine
2007; 261: 412–417.
Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nature Clinical Practice Nephrology
2006; 2: 700–707.
UNAIDS. How AIDS Changed Everything Report – 2015. Geneva: UNAIDS, 2015.
Pawlowski A, et al.
Tuberculosis and HIV Co-Infection. Plos Pathogens
2012; 8: e1002464.
UNAIDS. Access to Antiretroviral Therapy in Africa; Status Report on Progress Towards the 2015 Targets. Geneva: UNAIDS, 2013.
WHO. Antimicrobial Resistance; Global Report on Surveillance. Geneva: World Health Organisation, 2014.
Okeke IN, et al.
Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infectious Diseases
2005; 5: 481–493.
Hotamisligil GS. Inflammation and metabolic disorders. Nature
2006; 444: 860–867.
Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nature Reviews Clinical Oncology
2015; 12: 584–596.
Young F, et al.
A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health
2009; 5: 9.
Dillon DG, et al.
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. International Journal of Epidemiology
2013; 42: 1754–1771.
Brown TT, et al.
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine
2005; 165: 1179–1184.
De Wit S, et al.
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care
2008; 31: 1224–1229.
Triant VA, et al.
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism
2007; 92: 2506–2512.
Shintani Y, et al.
Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology
2004; 126: 840–848.
Marzouk D, et al.
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut
2007; 56: 1105–1110.
Wang CS, et al.
Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. American Journal of Epidemiology
2007; 166: 196–203.
Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences
2006; 3: 47–52.
Wang C, et al.
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. International Journal of Cancer Journal international du cancer
2012; 130: 1639–1648.
Genovese G, et al.
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science
2010; 329: 841–845.
Gaziano TA, et al.
Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations. BMC Medicine
2013; 11: 170.
Motala AA, et al.
The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diabetes Care
2011; 34: 1032–1037.
Crowther NJ, Norris SA. The current waist circumference cut point used for the diagnosis of metabolic syndrome in Sub-Saharan African women is not appropriate. PLoS ONE
2012; 7: e48883.
Mensah GA. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. Progress in Cardiovascular Diseases
2013; 56: 240–250.
Bonita R. Guest editorial: strengthening NCD prevention through risk factor surveillance. Global Health Action
2009; 2: 4–6.
Murphy GA, et al.
Cardiometabolic risk in a rural Ugandan population. Diabetes Care
2013; 36: e143.
Kahn K, et al.
Validation and application of verbal autopsies in a rural area of South Africa. Tropical Medicine & International Health: TM & IH
2000; 5: 824–831.
Asiki G, et al.
The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies. International Journal of Epidemiology
2013; 42: 129–141.
Ng N, et al.
Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scandinavian Journal of Public Health
2006; 34: 199–208.
WHO. WHO STEPS Instrument (Core and Expanded): The WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance (STEPS). Geneva: World Health Organization, 2016.
Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet
2006; 368: 1689–1695.
Maseko FC, Chirwa ML, Muula AS. Health systems challenges in cervical cancer prevention program in Malawi. Global Health Action
2015; 8: 26282.
Janssens B, et al.
Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bulletin of the World Health Organization
2007; 85: 880–885.
Atun R, et al.
Improving responsiveness of health systems to non-communicable diseases. Lancet
2013; 381: 690–697.
van Olmen J, et al.
Management of chronic diseases in Sub-Saharan Africa: cross-fertilisation between HIV/AIDS and diabetes care. Journal of Tropical Medicine
2012; 2012: 349312.
WHO. Package of Essenrtial Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva: World Health Organization, 2010.
Beaglehole R, et al.
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet
2008; 372: 940–949.
Maher D, et al.
Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Tropical Medicine & International Health: TM & IH
2010; 15: 176–181.
Mahomed OH, Asmall S. Development and implementation of an integrated chronic disease model in South Africa: lessons in the management of change through improving the quality of clinical practice. International Journal of Integrated Care
2015; 15: e038.
de-Graft Aikins A, Boynton P, Atanga LL. Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon. Globalization and Health
2010; 6: 6.
Aminkeng F, et al.
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent. Pharmacogenomics Journal
2014; 14: 160–170.
Ramos E, et al.
Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics Journal
2014; 14: 217–222.
Drain PK, et al.
Diagnostic point-of-care tests in resource-limited settings. Lancet Infectious Diseases
2014; 14: 239–249.
Pai NP, et al.
Barriers to implementation of rapid and point-of-care tests for human immunodeficiency virus infection: findings from a systematic review (1996–2014). Point of Care
2015; 14: 81–87.
Horton R. Offline: chronic diseases – the social justice issue of our time. Lancet
2016: 386: 2378.
Collins R. What makes UK Biobank special?
2012: 379: 1173–1174.